Tα1 reversed T-cell exhaustion (including CD8+ T and CD4+ T cells) and recovered immune reconstitution through promoting thymus output during severe acute respiratory syndrome-coronavirus 2 infection. Tα1 treatment significantly reduced mortality of severe COVID-19 patients. The gene discussed is CD8A; the disease is COVID-19.